Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Infiltrating Lymphocyte”

233 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 233 results

Early research (Phase 1)Not Yet RecruitingNCT07183852
What this trial is testing

Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Uveal MelanomaMetastatic Cutaneous Melanoma
Vastra Gotaland Region 18
Very early researchLooking for participantsNCT05098171
What this trial is testing

GC201 TIL in Advanced Gynecologic Tumors (10hospital)

Who this might be right for
Advanced Gynecologic TumorsSignal Switch Receptor Modified TILTreatment Side Effects+1 more
Shanghai Juncell Therapeutics 50
Early research (Phase 1)Active Not RecruitingNCT05470283
What this trial is testing

Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma

Who this might be right for
TumorMetastatic MelanomaMelanoma
M.D. Anderson Cancer Center 21
Early research (Phase 1)Looking for participantsNCT06084299
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Advanced Liver Cancer

Who this might be right for
Liver Cancer
Zhiyong Huang 16
Testing effectiveness (Phase 2)Study completedNCT02360579
What this trial is testing

Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Iovance Biotherapeutics, Inc. 220
Not applicableStudy completedNCT04377113
What this trial is testing

Cellular Immunity and Renal Cell Cancer

Who this might be right for
NK Cell Mediated ImmunityNK Cell Cytokine ProductionKidney Cancer
Clinical Hospital Center Rijeka 60
Testing effectiveness (Phase 2)Study completedNCT01585428
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

Who this might be right for
Cervical CancerOropharyngeal CancerVaginal Cancer+2 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Looking for participantsNCT06455917
What this trial is testing

TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients

Who this might be right for
Non-Small Cell Lung CancerLung Cancer (NSCLC)
University Hospital, Basel, Switzerland 30
Not applicableLooking for participantsNCT04068623
What this trial is testing

Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Centre Jean Perrin 90
Testing effectiveness (Phase 2)Looking for participantsNCT07288203
What this trial is testing

Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma

Who this might be right for
Melanoma (Skin Cancer)Unresectable MelanomaMetastatic Melanoma
Iovance Biotherapeutics, Inc. 100
Testing effectiveness (Phase 2)Looking for participantsNCT05639972
What this trial is testing

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Who this might be right for
HPV-Associated Cervical CarcinomaHPV-Related CarcinomaHPV-Related Malignancy+14 more
Christian Hinrichs 15
Testing effectiveness (Phase 2)WithdrawnNCT04389229
What this trial is testing

OVSTAR TIL Trial (OVarian Cancer Co-STimulatory Antigen Receptor TIL Trial)

Who this might be right for
Ovarian Cancer Metastatic
Immetacyte Ltd
Testing effectiveness (Phase 2)Study completedNCT04260529
What this trial is testing

CyPep-1 Injections in Cancer Inducing Lymphocyte Infiltrate Accumulations

Who this might be right for
Advanced Solid Tumor Malignancy
Cytovation AS 60
Very early researchUnknownNCT03347097
What this trial is testing

Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Huashan Hospital 40
Early research (Phase 1)Looking for participantsNCT06491225
What this trial is testing

Autologous Tumor-Infiltrating Lymphocyte (GTE-001 Injection ) for Treatment of Patients with Advanced Lung Adenocarcinoma

Who this might be right for
Advanced Lung Adenocarcinoma；Adult
Grit Biotechnology 12
Testing effectiveness (Phase 2)Study completedNCT01883323
What this trial is testing

Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy Following Cyclophosphamide And Fludarabine In Patients With Melanoma

Who this might be right for
Metastatic, Stage III or Stage IV, Melanoma
University Health Network, Toronto 12
Early research (Phase 1)Not Yet RecruitingNCT07256756
What this trial is testing

GC203 TIL in Advanced Solid Tumors (NF)

Who this might be right for
Solid Tumors, Adult
Shanghai Juncell Therapeutics 8
Testing effectiveness (Phase 2)Ended earlyNCT01995344
What this trial is testing

TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment

Who this might be right for
Metastatic Melanoma
The Christie NHS Foundation Trust 2
Early research (Phase 1)WithdrawnNCT06190249
What this trial is testing

Efficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable Melanoma

Who this might be right for
Stage IIIB MelanomaStage IIIC MelanomaStage IIID Melanoma
James Isaacs, MD
Very early researchLooking for participantsNCT05941936
What this trial is testing

A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors

Who this might be right for
Solid Tumor
Suzhou BlueHorse Therapeutics Co., Ltd. 5
Load More Results